Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



A natural approach to control induced fumonisin B1-histopathological nephrotoxic and hepatotoxic changes in rats

Ashraf A Khalil, Ashgan Abou Gabal, Amira A Abdellatef, Noha M Zahran, Sahar F Deraz.




Abstract
Cited by 0 Articles

Among liver and kidney diseases, mycotoxin contamination of feed has become a major concern in animal feed science. A case control study was conducted to evaluate the recovery efficiency of lactic acid bacteria on serum lipid profile parameters and histopathological changes of nephrotoxic and hepatotoxic mycotoxin fumonisin B1 (FB1)-induced toxicity in kidney and liver of rats. Eighteen rats were randomly assigned to 12 experimental groups fed various doses of FB1 and/or co-administrated Lactobacillus delbrueckii subsp. lactis DSM 20076 (LL-DSM) and Pediococcus acidilactici NNRL B-5627 (PA-NNRL) for a period of 28 days. After 2 weeks, no significant signs of toxicity in rats fed FB1 alone or co-administrated with LAB were observed. Treatments of LL-DSM and/or PA-NNRL had no effect on organs weight, lipid profile and histopathological examination of kidney and liver tissues along the experimental period. After 4 weeks, LDL + VLDL cholesterol, TG and TC were significantly increased, however the HDL-C, kidney and liver weights were significantly decreased in animals fed FB1 at doses tested. In the same line, the histopathological examination of livers and kidneys showed a series of morphological alterations in animals fed FB1 especially at the high dose (T200). Administration of LAB resulted in a significant improvement in all treatments tested as well as the histopathological patterns of liver and kidney tissues.

Key words: Histopathology, Lipid profile, Hepatotoxicity, Nephrotoxicity, Fumonisins, LAB, detoxification






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.